National
A second shot at marriage in Maine
State LGBT group hopes to bring issue before voters
The head of the statewide LGBT rights group in Maine is excited about the prospects for a November ballot measure that would legalize same-sex marriage.
Betsy Smith, executive director of Equality Maine, said during a Washington Blade interview on Saturday that a win in Maine on the initiative — the first voter-initiated pro-LGBT measure to appear on a state ballot anywhere in the country — would be “hugely significant.”
“Our opponents are always saying that we can win marriage in the courts and we can win marriage in the legislature … but when it comes to the people, we can never win marriage,” Smith said. “That’s the biggest thing. If we win at the ballot, it will be through the support of Mainers, of Americans, and that’s a really, really important statement that Americans are now believing that the freedom to marry is what should be the law of the country.”
Last week, Equality Maine — as well as allied groups Freedom to Marry and Gay & Lesbian Advocates & Defenders — submitted more than 105,000 signatures to Secretary of State Charles Summers, Jr., for certification of a ballot measure legalizing same-sex marriage. The number of names required for certification is 57,000, and Smith said she has significantly more than enough valid names to qualify for the ballot.
“There’s not a problem with the signatures,” Smith said. “We have, we think, around 85,000 to 90,000 valid signatures. So, in terms of validating, that’s not an issue.”
The secretary of state has 30 days to review the signatures and validate them, so the office will certify the measure by Feb. 26. Once the measure is certified, it won’t go directly to the ballot but to the Maine Legislature.
The legislature has three options. One would be passing the initiative on its own, an unlikely scenario that would result in the measure becoming law and the legalization of marriage rights for gay couples. Another, which Smith said she’s betting on, is the legislature indefinitely postponing action on the measure, sending it to voters after the lawmakers recess for the year in April.
But another option for the legislature that has drawn concern is the placing of an alternate question before voters alongside the proposition to legalize same-sex marriage. For example, the legislature could approve language asking voters to approve civil unions as an alternative to marriage, or same-sex marriage with extreme religious exemptions.
But Smith said she thinks the legislature won’t pursue this path, which could derail the effort to legalize same-sex marriage in Maine, because neither opponents nor supporters of same-sex marriage will want to go down that road.
“You’d have to have majority support for whatever you want to pass, so if it’s for civil unions, they would need to have a majority support civil unions,” Smith said. “Start thinking about where those votes come from. Well, the pro-marriage folks are not going to vote for it because we don’t want them to, and the anti-equality folks don’t support even civil unions for us, so when you start to add up how they get majority support, even though it’s a Republican legislature, it’s just really highly unlikely.”
But once the voter-initiated ballot measure is certified, the legislature can do nothing to kill it, so same-sex marriage would be on the ballot in Maine one way or the other.
November 2012 won’t be the first time that Maine voters have had to decide on the question of same-sex marriage. In 2009, Maine voters rejected a same-sex marriage law, signed by former Gov. John Baldacci (D), in a referendum by a vote of 53 percent.
Larry Sabato, a political scientist at the University of Virginia, said movement in favor of same-sex marriage within the American public at large and having President Obama at the top of the ticket bodes well for LGBT advocates the second time around at the ballot.
“While Maine is unusual politically, and can go back and forth between the parties and has an independent streak, it is very likely to back Obama again this fall,” Sabato said. “That probably helps passage. On the whole, I’d say it will be a tough fight, but prospects for approval are no worse than 50-50, and potentially could be better if the pro-marriage campaign is well run.”
One small change from 2009 that works in favor of passage is the change in the title for the measure. In 2009, the law was called “An Act To End Discrimination in Civil Marriage and Affirm Religious Freedom.” But the proposed title for the 2012 initiative is “An Act to Allow Marriage Licenses for Same-Sex Couples and Protect Religious Freedom.” Smith said research found this language played better with voters.
She said she believes an effective campaign will cost between $4 and $5 million. Although 2012 will be a competitive year and donors will have to make choices to give to the president, congressional races and ballot initiatives in other marriage states, Smith said her organization’s calculations “show we can raise that amount of money.”
But anti-gay forces are already making preparations to block these efforts.
Brian Brown, president of the National Organization for Marriage, in a statement last week pledged to fight the initiative and derided efforts to legalize marriage equality in Maine after the state rejected it in 2009.
“NOM intends to vigorously fight this attempt by same-sex marriage advocates to impose gay marriage in Maine,” Brown said. “Maine voters rejected gay marriage barely more than two years ago. What part of ‘no’ don’t gay marriage advocates understand?”
But Smith offered a litany of reasons why the outcome of a ballot measure in 2012 would be different. She said her organization made the decision to go to the ballot in December after it started gathering signatures last summer.
Among them, Smith said, are internal polls showing that support for same-sex marriage is somewhere between 53 and 54 percent.
“We have been running a public education initiative that we ramped up significantly in 2011, including knocking on 110,000 doors, having conversations with around 40,000 Mainers about why marriage matters in an effort to engage them in what we call a persuasion conversation,” Smith said.
Smith added her organization looked at the strength of the coalition and the willingness of volunteers to collect 105,000 names to put same-sex marriage on the ballot, which she said “indicated to us that volunteers are really excited and happy to get back involved.”
“So those are the … things that make 2012 different and led us to make the decision that we have the window of opportunity to win,” Smith concluded.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
Advocates say MTG bill threatens trans youth, families, and doctors
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Far-right José Antonio Kast elected Chile’s next president
Lighting candles in a time of exhaustion
In real estate, trust the process
-
Politics3 days agoLGBTQ Democrats say they’re ready to fight to win in 2026
-
District of Columbia2 days ago
Brian Footer suspends campaign for Ward 1 D.C. Council seat
-
Chile5 days ago
Far-right José Antonio Kast elected Chile’s next president
-
Opinions3 days ago
Lighting candles in a time of exhaustion
